Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 21;13(19):2183-2188.
doi: 10.1039/d1ay00072a. Epub 2021 May 6.

Development of a RPLC-UV method for monitoring uncleaved HIV-1 envelope glycoprotein

Affiliations

Development of a RPLC-UV method for monitoring uncleaved HIV-1 envelope glycoprotein

Nicole A Schneck et al. Anal Methods. .

Abstract

One of the HIV-1 vaccine design efforts has focused on developing a recombinant HIV-1 trimeric envelope glycoprotein (Env) as an immunogen to induce broadly neutralizing antibodies. A native-like immunogen, the BG505.DS.SOSIP.664 gp140 (Env) construct has been well-characterized as a vaccine candidate. This vaccine candidate comprises of three identical gp120 and truncated gp41 subunits that form into a trimer of heterodimers. During production, recombinant Env is expressed as a gp140 precursor polypeptide in which a furin cleavable site is engineered to generate a heterodimer of gp120 and gp41 subunits. Each heterodimer is connected by an intermolecular disulfide bond, and three heterodimers form into a trimer. Furin cleavage is an important factor to mimic native-like HIV-1 Env conformations and is needed to help induce an immune response. Therefore, it is critical to monitor cleavage for ensuring functionality of the Env vaccine product. In this paper, a new RPLC-UV method coupled with reduction was developed to routinely determine the percentage of uncleaved gp140 relative to the cleaved gp120 and gp41 subunits. Baseline separation was achieved among the gp120, gp41 and uncleaved gp140 peaks, thus enabling relative quantification of uncleaved gp140. Overall, this RPLC-UV approach has been successfully applied to support Env vaccine candidate developments.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Scheme of uncleaved and cleaved gp140 heterodimers. After reduction with DTT, cleaved gp140 dissociates into the gp120 and gp41 subunits while uncleaved gp140 cannot due to the hexa-arginine residue linker holding the two subunits together.
Fig. 2
Fig. 2
RPLC-UV chromatograms of Env under (a) non-reduced and (b) reduced conditions.
Fig. 3
Fig. 3
RPLC-UV chromatograms of Env under reduced conditions after being spiked with varying amounts of furin. Env sample was incubated with 0 μL (blue), 0.2 units (orange), 0.4 units (green), 1 unit (black), 2 units (red), and 10 units (purple) of furin. The teal trace was a negative control of 10 units of furin without Env.
Fig. 4
Fig. 4
RPLC-UV application for two different HIV-1 Env constructs: profiles of Env trimer constructs (a) BG505.DS.SOSIP.664 and (b) ConC-FP8v2 RnS-3mut-2G-SOSIP.664 after reduction by DTT.

References

    1. Sanders RW and Moore JP, Immunol. Rev, 2017, 275, 161–182. - PMC - PubMed
    1. Doores KJ, FEBS J, 2015, 282, 4679–4691. - PMC - PubMed
    1. Sanders RW, Derking R, Cupo A, Julien JP, Yasmeen A, de Val N, Kim HJ, Blattner C, de la Peña AT, Korzun J, Glabek M, de los Reyes K, Ketas TJ, van Gils MJ, King CR, Wilson IA, Ward AB, Klasse PJ and Moore JP, PLoS Pathog, 2013, 9, e1003618. - PMC - PubMed
    1. Georgiev IS, Joyce MG, Yang Y, Sastry M, Zhang B, Baxa U, Chen RE, Druz A, Lees CR, Narpala S, Schön A, Van Galen J, Chuang GY, Gorman J, Harned A, Pancera M, Stewart-Jones GB, Cheng C, Freire E, McDermott AB, Mascola JR and Kwong PD, J. Virol, 2015, 89, 5318–5329. - PMC - PubMed
    1. de Taeye SW, Moore JP and Sanders RW, Trends Immunol, 2016, 37, 221–232. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources